Inventor
SOKOL HAXHINASTO
Inventor
US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides25%
A61KPreparations for medical, dental or toiletry purposes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
A01KAnimal husbandry11%
C12NMicroorganisms or enzymes7%
C07CAcyclic or carbocyclic compounds4%
C07DHeterocyclic compounds4%
C07HSugars4%
C08BPolysaccharides4%
C08LCompositions of macromolecular compounds4%
PatentTitleYear
12,497,460Anti-MSR1 antibodies and methods of use thereof202512,471,579Mouse model of DITRA disease and uses thereof202512,209,180Bis-octahydrophenanthrene carboxamide derivatives and protein conjugates thereof for use as LXR agonists202512,060,428Anti-IL36R antibodies202411,825,819None202311,589,562Mouse model of DITRA disease and uses thereof202311,377,502Anti-MSR1 antibodies and methods of use thereof202211,267,893Anti-IL36R antibodies2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to REGENERON PHARMA (8)· patent assignee history
2022–2025Based in US· patent location history
2023Patents assigned to REGENERAN PHARMACEUTICALS INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| REGENERON PHARMA | 8 | 2022–2025 |
| REGENERAN PHARMACEUTICALS INC | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 8 | 2022–2025 |